$370.70
0.67%
NYSE, Nov 18, 03:59 pm EST. Closed.
ISIN
US50540R4092
Symbol
LH

Laboratory Stock price

$370.78
+51.95 16.29% 1M
+115.21 45.08% 6M
+119.90 47.79% YTD
+110.97 42.71% 1Y
+159.68 75.64% 3Y
+123.81 50.13% 5Y
+262.54 242.54% 10Y
+311.61 526.60% 20Y
NYSE, Closing price Wed, Nov 18 2026
+2.54 0.69%

Is Laboratory a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 9,085 stocks worldwide.

Key metrics

Basic
Market capitalization
$30.1b
Enterprise Value
$35.8b
Net debt
$5.7b
Cash
$261.8m
Shares outstanding
81.2m
Valuation
P/E
30.1
P/S | estimate
2.1 | 2.0
EV/Sales | estimate
2.5 | 2.3
EV/FCF | ex SBC
27.8 | 30.8
P/B
3.4
Dividends
DPS
$2.88
Yield 1Y | 5Y
0.8% | 1.1%
Growth 1Y | 5Y
0.0% | -
Payout 1Y | 3Y
27.5% | 35.1%
Increased
0 Years
Financials
Revenue | estimate
$14.6b | $15.3b
EBITDA
$1.9b
EBIT
$1.6b
Net Income
$1.0b
Free Cash Flow | ex SBC
$1.3b | $1.2b
Growth
Revenue | estimate
6.0% | 9.5%
EBITDA
18.6%
EBIT
20.4%
Net Income
17.4%
Free Cash Flow
-6.8%
Margin
Gross
29.0%
EBITDA
13.4%
EBIT
11.3%
Net
6.9%
Free Cash Flow | ex SBC
8.8% | 8.0%
Financial Health
Equity Ratio
46.9%
Return on Equity
10.2%
ROCE
10.2%
ROIC
7.7%
Debt/Equity
0.7
Share-Based Compensation & Dilution
SBC | % of Revenue
$127.1m | 0.9%
SBC as % of FCF
9.9%
SBC Growth 1Y
3.0%
Share Count Growth 1Y
-2.2%
Shareholder Yield
2.9%
More
EPS
$12.3
FCF per Share
$15.8
Short interest
3.1%
Employees
66k
Rev per Employee
$210.0k

Laboratory Stock Analysis

Unlock Scores for Free

Analyst Opinions

27 Analysts have issued a Laboratory forecast:

21x Buy
78%
6x Hold
22%

Analyst Opinions

27 Analysts have issued a Laboratory forecast:

Buy
78%
Hold
22%

Laboratory Events

Past Events
NOV
10
2026 UBS Global Healthcare Conference
9 days ago
OCT
28
Q3 2026 Earnings Call
22 days ago
SEP
15
Morgan Stanley 24th Annual Global Healthcare Conference
2 months ago
SEP
10
Analyst/Investor Day - Labcorp Holdings Inc.
2 months ago
JUL
30
Q2 2026 Earnings Call
4 months ago
JUN
3
Jefferies Global Healthcare Conference 2026
6 months ago
APR
30
Q1 2026 Earnings Call
7 months ago
FEB
17
Q4 2025 Earnings Call
9 months ago
JAN
13
44th Annual J.P. Morgan Healthcare Conference
10 months ago
OCT
28
Q3 2025 Earnings Call
about one year ago

Financial data from Laboratory

Sep '26
+/-
%
14,595 14,595
6% 6%
100%
- Direct Costs 10,367 10,367
5% 5%
71%
4,227 4,227
8% 8%
29%
- Selling and Administrative Expenses 2,278 2,278
0% 0%
16%
- Research and Development Expense - -
-
-
1,949 1,949
19% 19%
13%
- Depreciation and Amortization 305 305
10% 10%
2%
EBIT (Operating Income) EBIT 1,644 1,644
20% 20%
11%
Net Profit 1,004 1,004
17% 17%
7%

In millions USD.

Don't miss a Thing! We will send you all news about Laboratory directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Laboratory Stock News

Neutral
Market Watch
●
about 18 hours ago
Defensive sectors have beaten the S&P 500 by a wide margin in recent months, even though they are priced much higher relative to earnings estimates than the index.
Neutral
GlobeNewsWire
●
about 20 hours ago
DEERFIELD BEACH, Fla., Nov. 18, 2026 (GLOBE NEWSWIRE) -- OTraces, Inc., a diagnostics company developing proteomic blood tests for early cancer detection, today announced that it has selected Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, to perform reference laboratory testing for its Florida Department of Health–funded clinical trial evaluating the OT...
Neutral
PRNewsWire
●
one day ago
Expansion will bring clinical trial services closer to research sites and patients while supporting global studies BURLINGTON, N.C., Nov. 17, 2026 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced a collaboration with Grupo Fleury, one of Brazil's leading healthcare and diagnostic groups, with extensive laboratory infrastruc...
More Laboratory News

Company Profile

Laboratory Corp. of America Holdings is a clinical laboratory company. The firm engages in the provision of clinical laboratory and end-to-end drug development services. It operates through the following segments: LabCorp Diagnostics and Covance Drug Development. The LabCorp Diagnostics segment includes core testing as well as genomic and esoteric testing. The Covance Drug Development segment provides drug development solutions to companies in the pharmaceutical and biotechnology industries. The company was founded in 1971 and is headquartered in Burlington, NC.

Head office United States
CEO Mr. Schechter
Employees 66,385
Founded 1971
Website www.labcorp.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today